arrow left
arrow right
  • Patsy Young v. Aventis Inc., Avon Products, Inc., Block Drug Company, Inc. (Sued Individually And As Successor-In-Interest To The Gold Bond Sterilizing Powder Company A/K/A The Gold Bond Company), Block Drug Corporation (Sued Individually And As Successor-In-Interest To The Gold Bond Sterilizing Powder Company A/K/A The Gold Bond Company), Brenntag North America, Inc. (Sued Individually And As Successor-In-Interest To Mineral Pigment Solutions, Inc. And As Successor-In-Interest To Whittaker Clark & Daniels, Inc.), Brenntag Specialties, Inc. F/K/A Mineral Pigment Solutions, Inc. (Sued Individually And As Successor-In-Interest To Whittaker Clark & Daniels, Inc.), Charles B. Chrystal Company, Inc., Chattem, Inc. (Sued Individually And As Successor-In-Interest To Block Drug Corporation, Successor-In-Interest To The Gold Bond Sterilizing Powder Company A/K/A The Gold Bond Company), Colgate-Palmolive Company, Cyprus Amax Minerals Company (Sued Individually, Doing Business As, And As Successor To American Talc Company, Metropolitan Talc Co. Inc. And Charles Mathieu Inc. And Sierra Talc Company And United Talc Company), Cyprus Mines Corporation, Glaxosmithkline Llc (Sued Individually And As Successor-In-Interest To Block Drug Corporation, Successor-In-Interest To The Gold Bond Sterilizing Powder Company A/K/A The Gold Bond Company And As A Successor-In-Interest To Novartis Corporation And NOVARTIS CONSUMER HEALTH INC.), Gsk Consumer Health, Inc. F/K/A Novartis Consumer Health Inc. F/K/A Ciba Self-Medication, Inc., Insight Pharmaceuticals Corporation, A Subsidiary Of Prestige Brands Holdings, Inc., Insight Pharmaceuticals Llc, Macy'S Inc. F/K/A/ Federated Department Stores, Inc. (Sued Individually And As Successor-In-Interest To Twin Fair, Inc.), Novartis Corporation (Sued Individually And As A Successor-In-Interest To Ciba-Geigy Corporation And Its Subsidiaries Ciba Consumer Pharmaceuticals And Ciba Self-Medication, Inc.), Novartis Pharmaceuticals Corporation (Sued Individually And As Successor-In-Interest To Ciba-Geigy Corporation And Its Subsidiary Ciba Consumer Pharmaceuticals), Prestige Brands Holdings, Inc., Prestige Consumer Healthcare Inc. F/K/A Prestige Brands, Inc., Sanofi-Aventis U.S. Llc (Sued Individually And As Successor By Merger To Aventis Pharmaceuticals Inc.), Sanofi Us Services, Inc., Whittaker Clark & Daniels, Inc.Torts - Asbestos document preview
  • Patsy Young v. Aventis Inc., Avon Products, Inc., Block Drug Company, Inc. (Sued Individually And As Successor-In-Interest To The Gold Bond Sterilizing Powder Company A/K/A The Gold Bond Company), Block Drug Corporation (Sued Individually And As Successor-In-Interest To The Gold Bond Sterilizing Powder Company A/K/A The Gold Bond Company), Brenntag North America, Inc. (Sued Individually And As Successor-In-Interest To Mineral Pigment Solutions, Inc. And As Successor-In-Interest To Whittaker Clark & Daniels, Inc.), Brenntag Specialties, Inc. F/K/A Mineral Pigment Solutions, Inc. (Sued Individually And As Successor-In-Interest To Whittaker Clark & Daniels, Inc.), Charles B. Chrystal Company, Inc., Chattem, Inc. (Sued Individually And As Successor-In-Interest To Block Drug Corporation, Successor-In-Interest To The Gold Bond Sterilizing Powder Company A/K/A The Gold Bond Company), Colgate-Palmolive Company, Cyprus Amax Minerals Company (Sued Individually, Doing Business As, And As Successor To American Talc Company, Metropolitan Talc Co. Inc. And Charles Mathieu Inc. And Sierra Talc Company And United Talc Company), Cyprus Mines Corporation, Glaxosmithkline Llc (Sued Individually And As Successor-In-Interest To Block Drug Corporation, Successor-In-Interest To The Gold Bond Sterilizing Powder Company A/K/A The Gold Bond Company And As A Successor-In-Interest To Novartis Corporation And NOVARTIS CONSUMER HEALTH INC.), Gsk Consumer Health, Inc. F/K/A Novartis Consumer Health Inc. F/K/A Ciba Self-Medication, Inc., Insight Pharmaceuticals Corporation, A Subsidiary Of Prestige Brands Holdings, Inc., Insight Pharmaceuticals Llc, Macy'S Inc. F/K/A/ Federated Department Stores, Inc. (Sued Individually And As Successor-In-Interest To Twin Fair, Inc.), Novartis Corporation (Sued Individually And As A Successor-In-Interest To Ciba-Geigy Corporation And Its Subsidiaries Ciba Consumer Pharmaceuticals And Ciba Self-Medication, Inc.), Novartis Pharmaceuticals Corporation (Sued Individually And As Successor-In-Interest To Ciba-Geigy Corporation And Its Subsidiary Ciba Consumer Pharmaceuticals), Prestige Brands Holdings, Inc., Prestige Consumer Healthcare Inc. F/K/A Prestige Brands, Inc., Sanofi-Aventis U.S. Llc (Sued Individually And As Successor By Merger To Aventis Pharmaceuticals Inc.), Sanofi Us Services, Inc., Whittaker Clark & Daniels, Inc.Torts - Asbestos document preview
  • Patsy Young v. Aventis Inc., Avon Products, Inc., Block Drug Company, Inc. (Sued Individually And As Successor-In-Interest To The Gold Bond Sterilizing Powder Company A/K/A The Gold Bond Company), Block Drug Corporation (Sued Individually And As Successor-In-Interest To The Gold Bond Sterilizing Powder Company A/K/A The Gold Bond Company), Brenntag North America, Inc. (Sued Individually And As Successor-In-Interest To Mineral Pigment Solutions, Inc. And As Successor-In-Interest To Whittaker Clark & Daniels, Inc.), Brenntag Specialties, Inc. F/K/A Mineral Pigment Solutions, Inc. (Sued Individually And As Successor-In-Interest To Whittaker Clark & Daniels, Inc.), Charles B. Chrystal Company, Inc., Chattem, Inc. (Sued Individually And As Successor-In-Interest To Block Drug Corporation, Successor-In-Interest To The Gold Bond Sterilizing Powder Company A/K/A The Gold Bond Company), Colgate-Palmolive Company, Cyprus Amax Minerals Company (Sued Individually, Doing Business As, And As Successor To American Talc Company, Metropolitan Talc Co. Inc. And Charles Mathieu Inc. And Sierra Talc Company And United Talc Company), Cyprus Mines Corporation, Glaxosmithkline Llc (Sued Individually And As Successor-In-Interest To Block Drug Corporation, Successor-In-Interest To The Gold Bond Sterilizing Powder Company A/K/A The Gold Bond Company And As A Successor-In-Interest To Novartis Corporation And NOVARTIS CONSUMER HEALTH INC.), Gsk Consumer Health, Inc. F/K/A Novartis Consumer Health Inc. F/K/A Ciba Self-Medication, Inc., Insight Pharmaceuticals Corporation, A Subsidiary Of Prestige Brands Holdings, Inc., Insight Pharmaceuticals Llc, Macy'S Inc. F/K/A/ Federated Department Stores, Inc. (Sued Individually And As Successor-In-Interest To Twin Fair, Inc.), Novartis Corporation (Sued Individually And As A Successor-In-Interest To Ciba-Geigy Corporation And Its Subsidiaries Ciba Consumer Pharmaceuticals And Ciba Self-Medication, Inc.), Novartis Pharmaceuticals Corporation (Sued Individually And As Successor-In-Interest To Ciba-Geigy Corporation And Its Subsidiary Ciba Consumer Pharmaceuticals), Prestige Brands Holdings, Inc., Prestige Consumer Healthcare Inc. F/K/A Prestige Brands, Inc., Sanofi-Aventis U.S. Llc (Sued Individually And As Successor By Merger To Aventis Pharmaceuticals Inc.), Sanofi Us Services, Inc., Whittaker Clark & Daniels, Inc.Torts - Asbestos document preview
  • Patsy Young v. Aventis Inc., Avon Products, Inc., Block Drug Company, Inc. (Sued Individually And As Successor-In-Interest To The Gold Bond Sterilizing Powder Company A/K/A The Gold Bond Company), Block Drug Corporation (Sued Individually And As Successor-In-Interest To The Gold Bond Sterilizing Powder Company A/K/A The Gold Bond Company), Brenntag North America, Inc. (Sued Individually And As Successor-In-Interest To Mineral Pigment Solutions, Inc. And As Successor-In-Interest To Whittaker Clark & Daniels, Inc.), Brenntag Specialties, Inc. F/K/A Mineral Pigment Solutions, Inc. (Sued Individually And As Successor-In-Interest To Whittaker Clark & Daniels, Inc.), Charles B. Chrystal Company, Inc., Chattem, Inc. (Sued Individually And As Successor-In-Interest To Block Drug Corporation, Successor-In-Interest To The Gold Bond Sterilizing Powder Company A/K/A The Gold Bond Company), Colgate-Palmolive Company, Cyprus Amax Minerals Company (Sued Individually, Doing Business As, And As Successor To American Talc Company, Metropolitan Talc Co. Inc. And Charles Mathieu Inc. And Sierra Talc Company And United Talc Company), Cyprus Mines Corporation, Glaxosmithkline Llc (Sued Individually And As Successor-In-Interest To Block Drug Corporation, Successor-In-Interest To The Gold Bond Sterilizing Powder Company A/K/A The Gold Bond Company And As A Successor-In-Interest To Novartis Corporation And NOVARTIS CONSUMER HEALTH INC.), Gsk Consumer Health, Inc. F/K/A Novartis Consumer Health Inc. F/K/A Ciba Self-Medication, Inc., Insight Pharmaceuticals Corporation, A Subsidiary Of Prestige Brands Holdings, Inc., Insight Pharmaceuticals Llc, Macy'S Inc. F/K/A/ Federated Department Stores, Inc. (Sued Individually And As Successor-In-Interest To Twin Fair, Inc.), Novartis Corporation (Sued Individually And As A Successor-In-Interest To Ciba-Geigy Corporation And Its Subsidiaries Ciba Consumer Pharmaceuticals And Ciba Self-Medication, Inc.), Novartis Pharmaceuticals Corporation (Sued Individually And As Successor-In-Interest To Ciba-Geigy Corporation And Its Subsidiary Ciba Consumer Pharmaceuticals), Prestige Brands Holdings, Inc., Prestige Consumer Healthcare Inc. F/K/A Prestige Brands, Inc., Sanofi-Aventis U.S. Llc (Sued Individually And As Successor By Merger To Aventis Pharmaceuticals Inc.), Sanofi Us Services, Inc., Whittaker Clark & Daniels, Inc.Torts - Asbestos document preview
  • Patsy Young v. Aventis Inc., Avon Products, Inc., Block Drug Company, Inc. (Sued Individually And As Successor-In-Interest To The Gold Bond Sterilizing Powder Company A/K/A The Gold Bond Company), Block Drug Corporation (Sued Individually And As Successor-In-Interest To The Gold Bond Sterilizing Powder Company A/K/A The Gold Bond Company), Brenntag North America, Inc. (Sued Individually And As Successor-In-Interest To Mineral Pigment Solutions, Inc. And As Successor-In-Interest To Whittaker Clark & Daniels, Inc.), Brenntag Specialties, Inc. F/K/A Mineral Pigment Solutions, Inc. (Sued Individually And As Successor-In-Interest To Whittaker Clark & Daniels, Inc.), Charles B. Chrystal Company, Inc., Chattem, Inc. (Sued Individually And As Successor-In-Interest To Block Drug Corporation, Successor-In-Interest To The Gold Bond Sterilizing Powder Company A/K/A The Gold Bond Company), Colgate-Palmolive Company, Cyprus Amax Minerals Company (Sued Individually, Doing Business As, And As Successor To American Talc Company, Metropolitan Talc Co. Inc. And Charles Mathieu Inc. And Sierra Talc Company And United Talc Company), Cyprus Mines Corporation, Glaxosmithkline Llc (Sued Individually And As Successor-In-Interest To Block Drug Corporation, Successor-In-Interest To The Gold Bond Sterilizing Powder Company A/K/A The Gold Bond Company And As A Successor-In-Interest To Novartis Corporation And NOVARTIS CONSUMER HEALTH INC.), Gsk Consumer Health, Inc. F/K/A Novartis Consumer Health Inc. F/K/A Ciba Self-Medication, Inc., Insight Pharmaceuticals Corporation, A Subsidiary Of Prestige Brands Holdings, Inc., Insight Pharmaceuticals Llc, Macy'S Inc. F/K/A/ Federated Department Stores, Inc. (Sued Individually And As Successor-In-Interest To Twin Fair, Inc.), Novartis Corporation (Sued Individually And As A Successor-In-Interest To Ciba-Geigy Corporation And Its Subsidiaries Ciba Consumer Pharmaceuticals And Ciba Self-Medication, Inc.), Novartis Pharmaceuticals Corporation (Sued Individually And As Successor-In-Interest To Ciba-Geigy Corporation And Its Subsidiary Ciba Consumer Pharmaceuticals), Prestige Brands Holdings, Inc., Prestige Consumer Healthcare Inc. F/K/A Prestige Brands, Inc., Sanofi-Aventis U.S. Llc (Sued Individually And As Successor By Merger To Aventis Pharmaceuticals Inc.), Sanofi Us Services, Inc., Whittaker Clark & Daniels, Inc.Torts - Asbestos document preview
  • Patsy Young v. Aventis Inc., Avon Products, Inc., Block Drug Company, Inc. (Sued Individually And As Successor-In-Interest To The Gold Bond Sterilizing Powder Company A/K/A The Gold Bond Company), Block Drug Corporation (Sued Individually And As Successor-In-Interest To The Gold Bond Sterilizing Powder Company A/K/A The Gold Bond Company), Brenntag North America, Inc. (Sued Individually And As Successor-In-Interest To Mineral Pigment Solutions, Inc. And As Successor-In-Interest To Whittaker Clark & Daniels, Inc.), Brenntag Specialties, Inc. F/K/A Mineral Pigment Solutions, Inc. (Sued Individually And As Successor-In-Interest To Whittaker Clark & Daniels, Inc.), Charles B. Chrystal Company, Inc., Chattem, Inc. (Sued Individually And As Successor-In-Interest To Block Drug Corporation, Successor-In-Interest To The Gold Bond Sterilizing Powder Company A/K/A The Gold Bond Company), Colgate-Palmolive Company, Cyprus Amax Minerals Company (Sued Individually, Doing Business As, And As Successor To American Talc Company, Metropolitan Talc Co. Inc. And Charles Mathieu Inc. And Sierra Talc Company And United Talc Company), Cyprus Mines Corporation, Glaxosmithkline Llc (Sued Individually And As Successor-In-Interest To Block Drug Corporation, Successor-In-Interest To The Gold Bond Sterilizing Powder Company A/K/A The Gold Bond Company And As A Successor-In-Interest To Novartis Corporation And NOVARTIS CONSUMER HEALTH INC.), Gsk Consumer Health, Inc. F/K/A Novartis Consumer Health Inc. F/K/A Ciba Self-Medication, Inc., Insight Pharmaceuticals Corporation, A Subsidiary Of Prestige Brands Holdings, Inc., Insight Pharmaceuticals Llc, Macy'S Inc. F/K/A/ Federated Department Stores, Inc. (Sued Individually And As Successor-In-Interest To Twin Fair, Inc.), Novartis Corporation (Sued Individually And As A Successor-In-Interest To Ciba-Geigy Corporation And Its Subsidiaries Ciba Consumer Pharmaceuticals And Ciba Self-Medication, Inc.), Novartis Pharmaceuticals Corporation (Sued Individually And As Successor-In-Interest To Ciba-Geigy Corporation And Its Subsidiary Ciba Consumer Pharmaceuticals), Prestige Brands Holdings, Inc., Prestige Consumer Healthcare Inc. F/K/A Prestige Brands, Inc., Sanofi-Aventis U.S. Llc (Sued Individually And As Successor By Merger To Aventis Pharmaceuticals Inc.), Sanofi Us Services, Inc., Whittaker Clark & Daniels, Inc.Torts - Asbestos document preview
  • Patsy Young v. Aventis Inc., Avon Products, Inc., Block Drug Company, Inc. (Sued Individually And As Successor-In-Interest To The Gold Bond Sterilizing Powder Company A/K/A The Gold Bond Company), Block Drug Corporation (Sued Individually And As Successor-In-Interest To The Gold Bond Sterilizing Powder Company A/K/A The Gold Bond Company), Brenntag North America, Inc. (Sued Individually And As Successor-In-Interest To Mineral Pigment Solutions, Inc. And As Successor-In-Interest To Whittaker Clark & Daniels, Inc.), Brenntag Specialties, Inc. F/K/A Mineral Pigment Solutions, Inc. (Sued Individually And As Successor-In-Interest To Whittaker Clark & Daniels, Inc.), Charles B. Chrystal Company, Inc., Chattem, Inc. (Sued Individually And As Successor-In-Interest To Block Drug Corporation, Successor-In-Interest To The Gold Bond Sterilizing Powder Company A/K/A The Gold Bond Company), Colgate-Palmolive Company, Cyprus Amax Minerals Company (Sued Individually, Doing Business As, And As Successor To American Talc Company, Metropolitan Talc Co. Inc. And Charles Mathieu Inc. And Sierra Talc Company And United Talc Company), Cyprus Mines Corporation, Glaxosmithkline Llc (Sued Individually And As Successor-In-Interest To Block Drug Corporation, Successor-In-Interest To The Gold Bond Sterilizing Powder Company A/K/A The Gold Bond Company And As A Successor-In-Interest To Novartis Corporation And NOVARTIS CONSUMER HEALTH INC.), Gsk Consumer Health, Inc. F/K/A Novartis Consumer Health Inc. F/K/A Ciba Self-Medication, Inc., Insight Pharmaceuticals Corporation, A Subsidiary Of Prestige Brands Holdings, Inc., Insight Pharmaceuticals Llc, Macy'S Inc. F/K/A/ Federated Department Stores, Inc. (Sued Individually And As Successor-In-Interest To Twin Fair, Inc.), Novartis Corporation (Sued Individually And As A Successor-In-Interest To Ciba-Geigy Corporation And Its Subsidiaries Ciba Consumer Pharmaceuticals And Ciba Self-Medication, Inc.), Novartis Pharmaceuticals Corporation (Sued Individually And As Successor-In-Interest To Ciba-Geigy Corporation And Its Subsidiary Ciba Consumer Pharmaceuticals), Prestige Brands Holdings, Inc., Prestige Consumer Healthcare Inc. F/K/A Prestige Brands, Inc., Sanofi-Aventis U.S. Llc (Sued Individually And As Successor By Merger To Aventis Pharmaceuticals Inc.), Sanofi Us Services, Inc., Whittaker Clark & Daniels, Inc.Torts - Asbestos document preview
  • Patsy Young v. Aventis Inc., Avon Products, Inc., Block Drug Company, Inc. (Sued Individually And As Successor-In-Interest To The Gold Bond Sterilizing Powder Company A/K/A The Gold Bond Company), Block Drug Corporation (Sued Individually And As Successor-In-Interest To The Gold Bond Sterilizing Powder Company A/K/A The Gold Bond Company), Brenntag North America, Inc. (Sued Individually And As Successor-In-Interest To Mineral Pigment Solutions, Inc. And As Successor-In-Interest To Whittaker Clark & Daniels, Inc.), Brenntag Specialties, Inc. F/K/A Mineral Pigment Solutions, Inc. (Sued Individually And As Successor-In-Interest To Whittaker Clark & Daniels, Inc.), Charles B. Chrystal Company, Inc., Chattem, Inc. (Sued Individually And As Successor-In-Interest To Block Drug Corporation, Successor-In-Interest To The Gold Bond Sterilizing Powder Company A/K/A The Gold Bond Company), Colgate-Palmolive Company, Cyprus Amax Minerals Company (Sued Individually, Doing Business As, And As Successor To American Talc Company, Metropolitan Talc Co. Inc. And Charles Mathieu Inc. And Sierra Talc Company And United Talc Company), Cyprus Mines Corporation, Glaxosmithkline Llc (Sued Individually And As Successor-In-Interest To Block Drug Corporation, Successor-In-Interest To The Gold Bond Sterilizing Powder Company A/K/A The Gold Bond Company And As A Successor-In-Interest To Novartis Corporation And NOVARTIS CONSUMER HEALTH INC.), Gsk Consumer Health, Inc. F/K/A Novartis Consumer Health Inc. F/K/A Ciba Self-Medication, Inc., Insight Pharmaceuticals Corporation, A Subsidiary Of Prestige Brands Holdings, Inc., Insight Pharmaceuticals Llc, Macy'S Inc. F/K/A/ Federated Department Stores, Inc. (Sued Individually And As Successor-In-Interest To Twin Fair, Inc.), Novartis Corporation (Sued Individually And As A Successor-In-Interest To Ciba-Geigy Corporation And Its Subsidiaries Ciba Consumer Pharmaceuticals And Ciba Self-Medication, Inc.), Novartis Pharmaceuticals Corporation (Sued Individually And As Successor-In-Interest To Ciba-Geigy Corporation And Its Subsidiary Ciba Consumer Pharmaceuticals), Prestige Brands Holdings, Inc., Prestige Consumer Healthcare Inc. F/K/A Prestige Brands, Inc., Sanofi-Aventis U.S. Llc (Sued Individually And As Successor By Merger To Aventis Pharmaceuticals Inc.), Sanofi Us Services, Inc., Whittaker Clark & Daniels, Inc.Torts - Asbestos document preview
						
                                

Preview

FILED: ERIE COUNTY CLERK 03/03/2023 03:51 PM INDEX NO. 815818/2020 NYSCEF DOC. NO. 142 RECEIVED NYSCEF: 03/03/2023 EXHIBIT 30 FILED: ERIE COUNTY CLERK 03/03/2023 03:51 PM INDEX NO. 815818/2020 NYSCEF DOC. NO. 142 RECEIVED NYSCEF: 03/03/2023 COLGATE PALMOLIVE COMPANY RAW MATERIAL PURCHASE DESCRIPTION PLANT EFFECTIVE DATE SYMBOL NO. JC, JF, KC [ l-May-83 M-6020-3 TITLE: Italian Talc METHOD EXAMINAT ION DESCRIPTION 2252 Color See Below 2252 Odor Odorless or very slightly earthy 2252 Texture See Below (2) 2273 Apparent Density 0.82 +/- 0. lO gm./cc 2256 Fineness: Thru US #I00 Sieve [00% Thru US #200 Sieve 98% m±n. Thru US ~325 Sieve 65% mln. 4[0[ Alkalinity as Na20 2.0% max. 4163 Acid Soluble Iron as Fe203 0.?5% max. 2250 Arsenic as As 3 ppm max. 2286 Lead as Pb 20 ppm max, 4100 Soluble Matter in N/2 2.5% max. 2302 Microbial Contamination See below 2302 Bacteria Count [00/gm. max. (No gas forming organisms) FIbrous Asbestos (Serpentine, None detected by X-Ray Diffraction, Amphibole) Optical Microscopy**, TEM and Select- ed Area Electron D~ffraction, (I) Color: .~s~ not be darker than standard sample; must not change when heated to 200 *C. for 5 minutes, (2) Texture: Free of grit, with good slip and lustre, must match std. sample. Microbial Contamination: Run ~ost probable number test (Lab SPI 2302) using 15 tubes of Eugon Broth. Innoculate 5 tubes of fluid thlogycollate medium [5 tubes of Eugon Broth. Innoculate 5 tubes of fluid thlogycollate medium (containing dextrose) with 1.0ml of the 10% slurry. Incubate all tubes at 37"C for 48 hrs., inspecting for gas bubbles at [8-24 hours & 48 hours. * The supplier shall analyze for asbestos content (as listed above) and certify each shipment of Talc as being asbestos-free. Copies of certl- fication (containing analytical results) and pre-shipment sample of Talc should be furnished to R&D Sectlon Head-Current Toiltries and Q.A. Man- ager at the plant designated to receive the shipment at least 2 weeks prior to actual shipment. ** - in accordance with CTFA J-4-1. CAS Registry Number = 14807-96-6 Compound Control Number - 18774 Flash Point (TAG Closed Cup) = Not Applicable CHANGE : REASON FOR CP~NGE : Relnstat ement. To provide for additional source. EVERY EFFORT HAS BEEN MADE TO PROVIDE DESCRIPTION WHICH DEFINE THE QUALITY OF MATERIAL REQUIRED BY COL~TE FOR ITS INTENDED USE, HOWEVER IT IS TO BE UNDERSTOOD THAT AFTER REGULAR USE OF THE .MATERIAL HAS BEEN ESTABLISHED,THE SUPPLIER IS NOT AT LIBERTY TO MAKE CHANGES IN HIS RAW MATERIAL OR PROCESSES WHICH WILL ALTER THE CHEMICAL CObIPOS~TION OR THE PROPERTIES OF HIS PRODUCT IN ANY WAY, REGARDLESS OF SPECIFIED LIMITS, WITHOUT INFORMING COLGATE OF HIS INTENTIONS AND ALLOWING A REASONABLE PERIOD OF TIME FOR INVESTIGATION OF THE EFFECTS ON THE QUALITY OF FINISHED GOODS EACH SHIPPING UNIT TO BE OF UNIFORM SIZE AND S~IAPE, PLAINLY MARKED WITH SYMBOL NUMBER, QUANTITY AND OUR PURCHASE ONDER NUMBER R&D: QUAL. ASSUR.: MF : PURCH.: SUPERSEDES: DATED : ~ t~ / ~. L QE-CPCO0001411 FILED: ERIE COUNTY CLERK 03/03/2023 03:51 PM INDEX NO. 815818/2020 NYSCEF DOC. NO. 142 RECEIVED NYSCEF: 03/03/2023 TITLE: H-6020 Italian Talc SAMPLE TYPE: A - Grab Sample TKST KACH SHIPMENT FOR: Color Odor Texture Microbial Co~tamlnat ion Apparent Density Fineness QE-CPCO0001412 FILED: ERIE COUNTY CLERK 03/03/2023 03:51 PM INDEX NO. 815818/2020 NYSCEF DOC. NO. 142 RECEIVED NYSCEF: 03/03/2023 COLGATE PALMOLIVE COMPANY RAW .~TERIAL PURCHASE DESCRIPTION PLANT EFFECTIVE DATE SYMBOL NO. JC,JF,KC |l-May-83 M-6020-3 TITLE; Italian Talc HETHOD EXAMINATION DESCRIPTION 2252 Co Io r See Below (1) 2252 Odor Odorless or very slightly earthy 2252 Texture See Below (2) 2273 Apparent Density 0.82 +/- O. tO gm./cc 2256 Fineness: Thru US #100 Sieve I O0% Thru US #200 Sieve 98% mln. Thru US #325 Sieve 65% min. 410l Alkalinity as Na20 2.0% max. 4163 Acid Soluble Iron as Fe203 O. 75% max. 2250 Arsenic as As 3 ppm max. 2286 Lead as Pb 20 ppm max. 4 tO0 Soluble Hatter in N/2 2.5% max. 2302 Microbial Cont aminat ion See below 2302 Bacteria Count [00/gm. max, (No gas forming organisms) Fibrous Asbestos (Serpent the, None detected by X-Ray Diffraction, Amph lbo le) Optical Microscopy**, TEM and Select- ed Area Electron Diffraction. (i) Color: Must not be darker than standard sample; must not change when heated to 200 aC, for 5 minutes. (2) Texture: Free of grit, with good slip and lustre, must match std. sample. Microbial Contamination: Run most probable number test (Lab SPI 2302) using 15 tubes of Eugon Broth. Innoculate 5 tubes of fluid thlogycollate medium (containing dextrose) with [.Oml of the |0% slurry. Incubate all tubes at 37"C for 48 hrs., inspecting for gas bubbles at 18-24 hours & 48 hours. * The supplier shall analyze for asbestos content (as listed above) and certify each shipment of Talc as being asbestos-free. CopSes of certl- fication (containing analytical results) and pre-shipment sample of Talc should be furnished to R&D Section Head-Current Toiltries and Q.A. Man- ager at the plant designated to receive the shipment at least 2 weeks prior to actual shipment. ** - in accordance with CTFA CAS Registry Number -- 14807-96-6 Compound Control Number = 18774 Flash Point (TAG Closed Cup) = Not Appllcable. CHANGE: REASON FOR CHANGE: EVERY EFFORT HAS BEEN MADE TO PROVIDE DESCRIPTION WHICH DEFINE THE QUALITY OF MATERIAL REQUIRED BY COLGATE FOR ITS INTENDED USE, HOWEVER [T IS TO BE UNDERSTOOD THAT AFTER REGULAR USE OF THE MATERIAL HAS BEEN ESTABLISHED,THE SUPPLIER IS NOT AT LIBERTY TO MAKE CHANGES IN HIS RAW mATERIAL OR PROCESSES WHICH WILL ALTER THE CHEMICAL COMPOSITION OR THE PROPERTIES OF HIS PRODUCT IN ANY WAY, REGARDLESS OF SPECIFIED LIMITS, WITHOUT INFORMING COL~ATE OF HIS iNTENTIONS ANI~ ALLOWING A REASONABLE PERIOD OF TIME FOR INVESTIGATION OF THE EFFECTS ON THE QUALITY OF FINISHED GOODS EACH SHIPPING UNIT TO BE OF UNIFORM SIZE AND SHAPE, PLAINLY MARKED WITH SYMBOL NUMBER, QUANTITY AND OUR PURCHASE ORDER NUMBER R&D: QUAL. ASSUR. : MFG: P URCH. : SUPERSEDES : ~ .~ .o DATED : ,~/~ QE-CPCO0001413 FILED: ERIE COUNTY CLERK 03/03/2023 03:51 PM INDEX NO. 815818/2020 NYSCEF DOC. NO. 142 RECEIVED NYSCEF: 03/03/2023 COL CAT E- PA LMOL IVE COMPANY RAW MATERIAL PURCHASING SPECIFICATION PLANT EFFECTIVE DATE SYMBOL NO. JC, JF, KC M-6277-3 ~.~_~,~ _~ TITLE: Monltal 6040 Talc METHOD EXAMINAT ION S PEC tF ICAT ION 2252 Color See below (l) 2252 Odor Odorless or very slightly earthy 2252 Texture See below (2) 2273 Apparent Density 0.82 +/- 0.10 gm./cc. 2256 Fineness: Thru US il |00 sieve I00% Thru US II 200 sieve 98% Min. Thru US # 325 sieve 88% Min. 4101 ALkalinity as Na20 2.0% Max. 4163 Acid Soluble Iron as Fe203 O. 75% Max. 2250 Arsenic as As 3 ppm Max. ~517 Lead as Pb 20 ppm..Max. 4[00 Soluble Matter in N/2 HCI 2.0% Max. 2302 Mic rob Hal Cont amlnat ion See below 2302 Barter ia Count |00/gm. Max, (No gas formlng organisms) Fibrous Asbestos (Serpentine, None detected by X-ray Diffraction & Amph ibo le) Optical Microscopy**, TEM and Selected Area Electron Diffraction. (l) Color: Must not be darker than std. sample; must not change color when heated to 200%. for 5 minutes. (2) Texture: Free of grit, with good sllp & lustre, must match std. sample. Mtcroblal Contamination: Run most probable number test (Lab SPI 2302) using [5 tubes of Eugon Broth. Innoculate 5 tubes of fluid thiogiycolate medium (containing dextrose) with l.Omi o[ the 10% slurry. Incubate all tubes for 48 hrs. at 37=C, inspectlng for gas bubbles at 18-24 hours and 48hours. Supplier shall analyze for asbestos content (a~ Listed above) and certify each shipment of talc as being asbestos [~ee. Copies of. certification (con- taining analytlca[ results) & pre-shipment sample of talc should be furnished to R&D Section Head-Current Toiletries and Q.A..Manager at the pla~t design- ated to receive the shipment at least 2 weeks prior to actual shipment. ** in accordance with CTFA J-4-1 Methods. This material ts composed of 60% ~bntana Talc and 40% Italian Talc. CAS Reglst~y Number: 14807-96-6 Compound Cont¢ol Number: 19640 FLash Point (TAG Closed Cup): Not App[icab[e CHAN~E: REASON FOR CHANGE: Revising certification procedure. To simplify operations. EVERY EFFORT HAS BEEN MADE TO PROVIDE A SPECIFICATION WHICH DEFINES THE QUALI- TY OF MATERIAL REQUIRED BY COLCATE FOR ITS INTENDED USE. HOWEVER, [T IS TO BE UNDERSTOOD THAT AFTER REGULAR USE OF THE MATERIAL HAS BEEN ESTABLISHED, THE SUPPLIER [S NOT AT LIBERTY TO MAKE CHANGES [N HIS RAW MATERIAL OR PROCESSES, WHETHER OR NOT SUCH CHANGES ALTER THE CHEMICAL COMPOSITION OR THE PROPERTIES OF HIS PRODUCT IN ANY WAY, RE~d)LESS OF SPECIFIED LIMITS, WITHOUT INFORMING COLiATE OF HIS INTENTIONS AND ALLOWING A REASONABLE PER[Of) OF TIME FOR THE [NVESTIC4%TION OF THE EFFECTS ON THE QUALITY OF FINISHED GOODS. KACH SHIPPING UNIT TO BE OF UNIFORM SIZE AND SHAPE, PLAINLY MARKED WITH SYMBOL NUMBER, QUANTITY AND OUR PURCHASE ORDER N~MBER. REQUESTED BY: F. Schebece DATE TYPED: 03-Nov-83 SUPERSEDES; M-6277-2 R&D: ’~ ~,.’~ J Q.A.: MEG: PORCH.: DATED; ~ 6-dun-81 QE-CPCO0001414 FILED: ERIE COUNTY CLERK 03/03/2023 03:51 PM INDEX NO. 815818/2020 NYSCEF DOC. NO. 142 RECEIVED NYSCEF: 03/03/2023 TITLE: M-6277 Monlta[ 6040 Talc CLASS: [ SAMPLE TYPE: A- Grab Sample TEST EACH SHIPMENT FOR: Co[or Odo~ Texture M~ceob tal Contaminat ion Apparent Density Fineness QE-CPCO0001415